Literature DB >> 20299540

Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs.

Ravisankar A Ramadas1, Susan L Ewart, Benjamin D Medoff, Ann Marie LeVine.   

Abstract

Interleukin-1 (IL-1) is a proinflammatory cytokine that signals through the Type I IL-1 receptor (IL-1RI). Novel IL-1-like cytokines were recently identified. Their functions in lung disease remain unclear. Interleukin-1 family member-9 (IL-1F9) is one such IL-1-like cytokine, expressed in the lungs of humans and mice. IL-1F9 signals through IL-1 receptor-related protein 2 (IL-1Rrp2/IL-1RL2), which is distinct from IL-1RI. We sought to determine if IL-1F9 acts as a proinflammatory cytokine in lung disease. IL-1F9 protein was increased in lung homogenates of house dust mite-challenged A/J mice compared with controls, and expression was seen in airway epithelial cells. The intratracheal administration of recombinant mouse IL-1F9 increased airway hyperresponsiveness and induced neutrophil influx and mucus production, but not eosinophilic infiltration in the lungs of mice. In addition, IL-1α protein levels in bronchoalveolar lavage fluid, chemokines, and chemokine-receptor mRNA expression in the lungs were increased after the instillation of intratracheal IL-1F9. Consistent with these changes, NF-κB transcription factor activity was increased in the lungs of mice challenged with IL-1F9 and in a macrophage cell line treated with IL-1F9. These data suggest that IL-1F9 is upregulated during inflammation, and acts as a proinflammatory cytokine in the lungs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299540      PMCID: PMC3049228          DOI: 10.1165/rcmb.2009-0315OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  41 in total

1.  IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response.

Authors:  Susumu Nakae; Yutaka Komiyama; Hiroshi Yokoyama; Aya Nambu; Masaomi Umeda; Michiko Iwase; Ikuo Homma; Katsuko Sudo; Reiko Horai; Masahide Asano; Yoichiro Iwakura
Journal:  Int Immunol       Date:  2003-04       Impact factor: 4.823

2.  Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.

Authors:  Christophe Desmet; Philippe Gosset; Bernard Pajak; Didier Cataldo; Mohamed Bentires-Alj; Pierre Lekeux; Fabrice Bureau
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

3.  Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

4.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

5.  Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats.

Authors:  J A Leff; J W Baer; M E Bodman; J M Kirkman; P F Shanley; L M Patton; C J Beehler; J M McCord; J E Repine
Journal:  Am J Physiol       Date:  1994-01

6.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.

Authors:  Jennifer E Towne; Kirsten E Garka; Blair R Renshaw; G Duke Virca; John E Sims
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

7.  Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma.

Authors:  Rosalia Gagliardo; Pascal Chanez; Marc Mathieu; Andreina Bruno; Giorgia Costanzo; Claire Gougat; Isabelle Vachier; Jean Bousquet; Giovanni Bonsignore; Antonio M Vignola
Journal:  Am J Respir Crit Care Med       Date:  2003-07-31       Impact factor: 21.405

8.  NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.

Authors:  A Ueda; K Okuda; S Ohno; A Shirai; T Igarashi; K Matsunaga; J Fukushima; S Kawamoto; Y Ishigatsubo; T Okubo
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

Review 9.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  Modulation by cAMP of IL-1beta-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells.

Authors:  W A Wuyts; B M Vanaudenaerde; L J Dupont; M G Demedts; G M Verleden
Journal:  Eur Respir J       Date:  2003-08       Impact factor: 16.671

View more
  52 in total

1.  IL-36γ Promotes Killing of Mycobacterium tuberculosis by Macrophages via WNT5A-Induced Noncanonical WNT Signaling.

Authors:  Yuchi Gao; Qian Wen; Shengfeng Hu; Xinying Zhou; Wenjing Xiong; Xialin Du; Lijie Zhang; Yuling Fu; Jiahui Yang; Chaoying Zhou; Zelin Zhang; Yanfen Li; Honglin Liu; Yulan Huang; Li Ma
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

2.  The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ.

Authors:  Li-Hua Lian; Katelynn A Milora; Katherine K Manupipatpong; Liselotte E Jensen
Journal:  J Invest Dermatol       Date:  2012-02-09       Impact factor: 8.551

3.  Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells.

Authors:  Regina T Chustz; Deepti R Nagarkar; Julie A Poposki; Silvio Favoreto; Pedro C Avila; Robert P Schleimer; Atsushi Kato
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

Review 4.  The airway epithelium in asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

5.  Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

Authors:  James DeVoti; Lynda Hatam; Alexandra Lucs; Ali Afzal; Allan Abramson; Bettie Steinberg; Vincent Bonagura
Journal:  Mol Med       Date:  2014-08-28       Impact factor: 6.354

6.  CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.

Authors:  Benjamin Causton; Ravisankar A Ramadas; Josalyn L Cho; Khristianna Jones; Ana Pardo-Saganta; Jayaraj Rajagopal; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

7.  IL-36γ Protects against Severe Influenza Infection by Promoting Lung Alveolar Macrophage Survival and Limiting Viral Replication.

Authors:  Alexander N Wein; Paul R Dunbar; Sean R McMaster; Zheng-Rong Tiger Li; Timothy L Denning; Jacob E Kohlmeier
Journal:  J Immunol       Date:  2018-05-30       Impact factor: 5.422

8.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

9.  Deoxycholic acid inhibited proliferation and induced apoptosis and necrosis by regulating the activity of transcription factors in rat pancreatic acinar cell line AR42J.

Authors:  Guixin Zhang; Jingwen Zhang; Dong Shang; Bing Qi; Hailong Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-20       Impact factor: 2.416

Review 10.  The role of interleukin-1 family members in the host defence against Aspergillus fumigatus.

Authors:  Mark S Gresnigt; Frank L van de Veerdonk
Journal:  Mycopathologia       Date:  2014-07-22       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.